drugset / Trial / NCT07474350

Valethamate Bromide Versus Hyoscine Butyl Bromide in Reducing Labour Duration Among Primigravida

NCT07474350

Completed 165 enrolled Federal Teaching Hospital Abakaliki
RandomizedParallel-groupSingle-blindSupportive care

Summary

Labour is a physiological process that enables the natural delivery of fetus, placenta and membranes after the age of viability. This study compared the efficacy of valethamate bromide and hyoscine butyl bromide in reducing labour duration among primigravid women at Alex Ekwueme Federal University Teaching Hospital, Abakaliki

Timeline

Start
2023-09-01
Primary completion
2024-01-23
Completion
2024-01-23

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hyoscine butylbromide Unknown 40 mg Intravenous
Subject VALETHAMATE Small molecule 16 mg Intravenous

Indications

No indication recorded.